KR20130109171A - 대장암(colorectal cancer) 치료용 폴리에틸렌글리콜(PEG) 또는 PEG 블럭 공중합체 - Google Patents

대장암(colorectal cancer) 치료용 폴리에틸렌글리콜(PEG) 또는 PEG 블럭 공중합체 Download PDF

Info

Publication number
KR20130109171A
KR20130109171A KR1020137013977A KR20137013977A KR20130109171A KR 20130109171 A KR20130109171 A KR 20130109171A KR 1020137013977 A KR1020137013977 A KR 1020137013977A KR 20137013977 A KR20137013977 A KR 20137013977A KR 20130109171 A KR20130109171 A KR 20130109171A
Authority
KR
South Korea
Prior art keywords
peg
composition
polyethylene glycol
weight
crc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137013977A
Other languages
English (en)
Korean (ko)
Inventor
피터 스테인
이안 콕스
사무엘 스미스
레이튼 존스
호그 프레슬
코린 드브리스
레이첼 찰튼
Original Assignee
노어긴 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노어긴 비.브이. filed Critical 노어긴 비.브이.
Publication of KR20130109171A publication Critical patent/KR20130109171A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
KR1020137013977A 2010-11-04 2011-11-04 대장암(colorectal cancer) 치료용 폴리에틸렌글리콜(PEG) 또는 PEG 블럭 공중합체 Ceased KR20130109171A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
GB1018650.0 2010-11-04
US41212810P 2010-11-10 2010-11-10
US61/412,128 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
KR20130109171A true KR20130109171A (ko) 2013-10-07

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137013977A Ceased KR20130109171A (ko) 2010-11-04 2011-11-04 대장암(colorectal cancer) 치료용 폴리에틸렌글리콜(PEG) 또는 PEG 블럭 공중합체

Country Status (22)

Country Link
US (2) US20130216493A1 (enExample)
EP (1) EP2635289B1 (enExample)
JP (1) JP5917537B2 (enExample)
KR (1) KR20130109171A (enExample)
CN (1) CN103313719A (enExample)
AR (1) AR083770A1 (enExample)
AU (1) AU2011324996B2 (enExample)
BE (1) BE1019494A3 (enExample)
BR (1) BR112013011012A2 (enExample)
CA (1) CA2816839A1 (enExample)
EA (1) EA201300540A1 (enExample)
ES (1) ES2401269B1 (enExample)
GB (1) GB201018650D0 (enExample)
MX (1) MX349690B (enExample)
MY (1) MY163067A (enExample)
NL (1) NL2007715C2 (enExample)
NZ (1) NZ611145A (enExample)
SG (1) SG189533A1 (enExample)
TW (1) TWI606832B (enExample)
UA (1) UA107998C2 (enExample)
WO (1) WO2012059725A1 (enExample)
ZA (1) ZA201304052B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
NZ743984A (en) 2012-09-11 2019-10-25 Norgine Bv Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
CN113507933B (zh) * 2019-03-05 2024-05-10 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
CN113473996B (zh) 2019-03-05 2024-05-24 陶氏环球技术有限责任公司 诱导胱天蛋白酶活性
JP7487220B2 (ja) * 2019-03-05 2024-05-20 ダウ グローバル テクノロジーズ エルエルシー カスパーゼ活性を誘導するためのポリエチレングリコール誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
AU2011324996B2 (en) 2015-10-08
EP2635289A1 (en) 2013-09-11
MX349690B (es) 2017-08-09
TW201304785A (zh) 2013-02-01
WO2012059725A8 (en) 2013-05-30
MX2013004963A (es) 2013-08-27
ES2401269A1 (es) 2013-04-18
AR083770A1 (es) 2013-03-20
CA2816839A1 (en) 2012-05-10
ES2401269B1 (es) 2014-02-19
CN103313719A (zh) 2013-09-18
ZA201304052B (en) 2014-02-26
UA107998C2 (uk) 2015-03-10
EA201300540A1 (ru) 2013-09-30
BE1019494A3 (fr) 2012-07-03
EP2635289B1 (en) 2020-03-11
TWI606832B (zh) 2017-12-01
WO2012059725A1 (en) 2012-05-10
JP2013544809A (ja) 2013-12-19
JP5917537B2 (ja) 2016-05-18
US20160228467A1 (en) 2016-08-11
BR112013011012A2 (pt) 2016-08-23
NL2007715A (en) 2012-05-07
SG189533A1 (en) 2013-05-31
GB201018650D0 (en) 2010-12-22
AU2011324996A1 (en) 2013-05-02
NZ611145A (en) 2015-07-31
MY163067A (en) 2017-08-15
US20130216493A1 (en) 2013-08-22
NL2007715C2 (en) 2012-10-16

Similar Documents

Publication Publication Date Title
US9089528B2 (en) Liquid compositions of calcium acetate
TWI606832B (zh) 方法及組成物
JP5872573B2 (ja) ポリエチレングリコール含有製剤
Schauben et al. Iron poisoning: Report of three cases and a review of therapeutic intervention
JP2013540726A (ja) 便秘薬
IL225891A (en) Peg or block peg copolymers for the treatment of colorectal cancer
Patel Development of Novel Sustained Release Formulations for Older Adults With Swallowing Difficulties
JP2005529871A (ja) 高血圧症の予防および治療のための低用量カリウム補充
Hale et al. 20 Breastfeeding and the Use of Medications

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130530

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20161102

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170822

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180427

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170822

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I